Consensus statement: Management of oral anticoagulation for stroke prevention in patients with nonvalvular atrial fibrillation

With the introduction of edoxaban last year in Germany, four nonvitamin K antagonist oral anticoagulants are now available for stroke prevention in patients with nonvalvular atrial fibrillation. These novel oral anticoagulants (NOAC) represent an attractive new option compared to vitamin K antagonis...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Herzschrittmachertherapie & Elektrophysiologie 2016-09, Vol.27 (3), p.295-306
Hauptverfasser:	Helms, Thomas Maria, Silber, Sigmund, Schäfer, Andreas, Masuhr, Florian, Palm, Frederick, Darius, Harald, Schrör, Karsten, Bänsch, Dietmar, Bramlage, Peter, Hankowitz, Johannes, Karle, Christoph A, Stargardt, Tom, Weil, Joachim, Geller, Johann Christoph
Format:	Artikel
Sprache:	ger
Schlagworte:	Administration, Oral Anticoagulants - administration & dosage Atrial Fibrillation - complications Atrial Fibrillation - drug therapy Cardiology - standards Evidence-Based Medicine - standards Germany Heart Valve Diseases - complications Heart Valve Diseases - drug therapy Practice Guidelines as Topic Stroke - etiology Stroke - prevention & control Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!